Occident

Investor type

VC / Family office

Founded

1993

AUM

-

Location

Munich, Bavaria, Germany

Investment Ticket

$0-1 m

Investment Stage

Late Stage (Series C+) Series B Series A Seed

Region of investment

Europe
Investor profile last updated: 31 August, 2026

Profile

Occident is a venture capital investor based in Munich, Germany, and Zug, Switzerland, founded in 2012. The firm is owner-managed and invests its own wealth, focusing on deep-tech startups, particularly those originating from scientific research. Occident's team consists of 7 professionals who are dedicated to supporting startups from the seed stage onwards, with a strong emphasis on sustainable and impactful investments.

Occident invests primarily in the life sciences and industrial tech sectors, with a focus on spin-offs from scientific research. The firm typically participates in seed and Series A rounds, with investments spread across Germany and Switzerland. Occident's portfolio includes companies such as Hemotune, Tubulis, and Lymphatica Medtech. The firm is known for its long-term commitment to its portfolio companies, providing both financial support and strategic guidance.

Notable investments by Occident include Hemotune - therapeutic devices, Tubulis - drug discovery, and Lymphatica Medtech - therapeutic devices. Occident has also participated in significant funding rounds, such as the €300 million Series C round for Tubulis, co-led by Venrock Healthcare Capital Partners.

Industry

Mobility HealthTech VR/AR Life Sciences MedTech Blockchain/Crypto Telecommunications SaaS Media and Entertainment IT Services Industrial Healthcare Services Fintech Financial Services Digital Biotechnology Deeptech

Contacts

Name
Title
Email
avatar
Michael Pauer Investment Director
Investment Director
-
avatar
Aagam Shah, PhD Investment Analyst
Investment Analyst
-
Upgrade to see contacts
avatar
sJSvqmG2ARfgjOTZ sJSvqmG2ARfgjOTZ
sJSvqmG2ARfgjOTZ
avatar
sJSvqmG2ARfgjOTZ sJSvqmG2ARfgjOTZ
sJSvqmG2ARfgjOTZ
avatar
sJSvqmG2ARfgjOTZ sJSvqmG2ARfgjOTZ
sJSvqmG2ARfgjOTZ
Investment-team contacts for Occident — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Occident

Occident is a venture capital firm that also operates as a family office. It backs companies at Late Stage (Series C+), Series B, Series A and Seed, writing tickets of $0-1 m.
Occident is located in Munich, Bavaria, Germany.
Occident was founded in 1993.
Occident invests in companies and startups in Mobility, HealthTech, VR/AR, Life Sciences, MedTech, Blockchain/Crypto, Telecommunications, SaaS, Media and Entertainment, IT Services, Industrial, Healthcare Services, Fintech, Financial Services, Digital, Biotechnology, Deeptech.
Occident invests in companies and startups in Europe.
Occident invests in companies and startups at Late Stage (Series C+), Series B, Series A, Seed.
Occident usually invests $0-1 m on average.
Occident can be reached through its website occident.group, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Occident — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Occident directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 31 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.